Drug intelligence / Profile preview

Surgicel NU-KNIT

Development stage
Unknown
Lead developer
Ethicon
Administration
Topical
01

Overview

Surgicel NU-KNIT is a sterile, absorbable knitted hemostatic fabric composed of oxidized regenerated cellulose (ORC), engineered as a dense, high–tensile-strength variant within Ethicon’s Surgicel family for control of continuous oozing bleeding in surgery.[1][4] It acts as a topical adjunctive hemostat: upon contact with blood it swells into a gelatinous mass that provides a physical matrix for platelet adhesion and aggregation and lowers local pH, promoting vasoconstriction and clot formation while creating an environment that is bactericidal in vitro against a broad range of gram‑positive and gram‑negative organisms.[1][2][4] The material is bioabsorbable over roughly 7–14 days (variable with amount, saturation, and tissue bed), can be cut to size including for endoscopic use, and is intended for capillary, venous, and small arterial hemorrhage when ligation or conventional methods are impractical or ineffective, across diverse procedures such as abdominal, thoracic, neurosurgical, orthopedic, cardiovascular, otorhinolaryngologic, and oral surgeries.[1][3][4]

Brand names
Surgicel NU-KNIT
Other names
Surgicel NU-KNIT Absorbable HemostatSurgicel NU-KNIT Absorbable Hemostat (oxidized regenerated cellulose)Surgicel Absorbable Hemostat NU-KNIT

Beyond the preview

Go deeper on Surgicel NU-KNIT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Surgicel NU-KNIT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call